Rare diseases
Investigational molecules
Locations
Taarnbygget, Kirkeveien 166, 0450 Oslo, Norway
Research activity includes follicular lymphoma, multiple myeloma, acute lymphoblastic leukemia, lymphoblastic lymphoma, and graft-versus-host disease, with a strong interest in targeted immune-based treatment strategies and disease monitoring in blood cancers.
Additional work spans minimal residual disease-guided treatment, CAR T-cell therapy, and vaccine-based immunotherapy in relapsed or high-risk haematological malignancies.
Oslo University Hospital HF runs clinical trials in conditions such as Renal transplant, Plasma cell myeloma, Arteriovenous malformation, Juvenile idiopathic arthritis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
NorwayNorway
DenmarkNorwayNorwayNorwayNorwayNorwayDenmarkNorwayNorwayNorwayIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
